Suchergebnisse - "Bodrogi, István"

PubPharm (61)

1

Neutrophil-to-lymphocyte ratio in primary mediastinal germ cell tumors : A retrospective analysis of >20 years single institution experience

enthalten in: Current problems in cancer | 2020

von Géczi, L. | Budai, B. | Polk, N. | +3

2

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

enthalten in: Cancer research | 2020

von Patel, V. | Busch, E. | Friebel, T. | +98

CommentIn: J Urol. 2020 Sep;204(3):619-620. - PMID 32586171

3

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma : a Retrospective Trial and Combined Case Reports from Literature

enthalten in: Pathology oncology research : POR | 2019

von Nagyiványi, K. | Budai, B. | Küronya, Z. | +4

4

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature

enthalten in: Pathology oncology research | 2017

von Nagyiványi, K. | Budai, B. | Küronya, Z. | +4

5

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature

enthalten in: Pathology & oncology research | 2017

von Nagyiványi, K. | Budai, B. | Küronya, Z. | +4

6

Outcome of Restarted Sunitinib Treatment in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Trial and Combined Case Reports from Literature

enthalten in: Pathology & oncology research | 2017

von Nagyiványi, K. | Budai, B. | Küronya, Z. | +4

7

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia : Combined Subgroup Analyses of the RECORD-1 and REACT Trials

enthalten in: Clinical genitourinary cancer | 2016

von Bono, P. | Oudard, S. | Bodrogi, I. | +14

CommentIn: Clin Genitourin Cancer. 2017 Feb;15(1):e53-e54. - PMID 27524511

8

First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer

enthalten in: Magyar onkologia | 2013

von Maráz, A. | Bodrogi, I. | Csejtei, A. | +7

9

An international expanded-access programme of everolimus : addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2012

von Grünwald, V. | Karakiewicz, P. | Bavbek, S. | +116

10

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

enthalten in: The European journal of cancer / A | 2012

von Grünwald, V. | Karakiewicz, P. | Bavbek, S. | +15

1
2
3
4
5
6
7
Nächster »
[7]